The use of Liposcale® Test in Premature Cardiovascular disease

Jounal of Clinical Med

Last week, a new paper, which evaluates the use of the Liposcale® test as a predictor of premature cardiovascular disease (PRESARV-SEA Study), was published. Beyond levels of LDL-C, results reported in the article support the relevance of LDL cholesterol composition and size on premature cardiovascular disease progression and its potential as a new biomarker for […]